OncoDaily
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
OncoDaily
Jan 30, 2024, 19:29 |
Blog
Vrouyr Bilemjian: We have developed a tumor targeting drug delivery systems
Vrouyr Bilemjian, Solutions and Strategy Consultant at Innoplexus, made the following post on LinkedIn: "Excited…
Jan 30, 2024, 16:57 |
Blog
Daniel Stover: Honored to have the opportunity to review some high impact abstracts with the amazing Onc Brothers
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared a…
Jan 30, 2024, 16:49 |
Blog
Stacey Tinianov: The reality of 'manageable and tolerable' side effects as well as risk reduction and management
Stacey Tinianov, Vice President of Patient Advocacy and Engagement at Rabble Health, shared a post by…
Jan 30, 2024, 16:44 |
Opinion
Dimitrios Makrakis: Proud to represent NYC Health + Hospitals/Jacobi at ASCO GU24
Dimitrios Makrakis, an Internal Medicine Resident at Albert Einstein College of Medicine, recently posted on…
Jan 30, 2024, 16:37 |
Insight
Ruben Mesa: Outstanding work Lejla Hadzikadic Gusic and the amazing Young Women’s Breast Cancer Team at our Levine Cancer Institute
Ruben Mesa, President at Atrium Health, recently shared a post by Lejla Hadzikadic Gusic, Program…
Jan 30, 2024, 16:31 |
Insight
Erika Hamilton: This is what drove the recommendations for colonoscopy to start at 45, not 50 like it used to be
Erika Hamilton recently shared a post by Samu Shiva, Physician Lead of Lifestyle Medicine and…
Jan 30, 2024, 16:28 |
Blog
Toni Choueiri: OS benefit in adjuvant Renal Cancer is finally here
Toni Choueiri, Medical Doctor and Professor at Dana-Farber Cancer Institute, recently posted on LinkedIn: "51…
Jan 30, 2024, 16:17 |
Blog
The London Borough of Sutton have appointed insurer Aviva and developer Socius as partners to develop a five-acre site next to our Sutton site - The Institute of Cancer Research
Jan 30, 2024, 16:13 |
Blog
Chandler Park: Gleason 3+3=6 should NOT be considered a 'cancer'
Chandler Park, Kentucky Physician Representative of the ASCO State Executive Council, shared on X/Twitter: "Gleason…
Jan 30, 2024, 15:58 |
Blog
Awi Lifshitz: OpenAI launched their GPT store and already numerous tools can save you lot of time and money
Awi Lifshitz, CEO at weXelerate, posted on LinkedIn: "Attention anyone building or advising early-stage startups.…
Jan 30, 2024, 15:54 |
Blog
Let's acknowledge the caregivers, friends, and families as the International Quality of Life Month comes to its end
January is International Quality of Life Month, a time to reflect on the challenges faced…
Jan 30, 2024, 15:51 |
Insight
Manni Mohyuddin: It is often well known that the control arm is inferior prior to a single patient being enrolled on trial!
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute, University of Utah, shared on X/Twitter:…
Jan 30, 2024, 15:45 |
Societies
Chiara Mercinelli: An honor to present Nure Combo trial at ASCO GU24
Chiara Mercinelli, Fellow Research Oncology Resident IRCCS San Raffaele, posted on X/Twitter: "It has been…
Jan 30, 2024, 15:41 |
Blog
Ido Didi Fabian: First review paper summarizing a new research field in medicine
Ido Didi Fabian, Head of Sheba Global Ophthalmology and PI of the Global Retinoblastoma Study Group,…
Jan 30, 2024, 14:58 |
Insight
Earle Burgess: How should we incorporate the results of the Embark trial
Earle Burgess, Genitourinary Medical Oncologist at Atrium Health Levine Cancer, posted on LinkedIn: "How should we…
Jan 30, 2024, 14:46 |
Societies
EORTC - The first-ever comparison between a Knowledge-Based Planning and a Deep Learning solution for breast cancer radiotherapy
EORTC posted on LinkedIn: "We are proud to share a new EORTC publication led by…
Jan 30, 2024, 14:37 |
Blog
How the international nature of science makes him feel at home - The Nobel Prize
The Nobel Prize posted on LinkedIn: ""I found my tribe. The tribe of science." At…
Jan 30, 2024, 11:39 |
Career
Armine Badeyan: My case report was chosen to be featured in the home page of Radiopaedia!
Armine Badeyan, Acting Director at Radioisotope Production Center, Yerevan, shared on Facebook: "How can I…
Jan 30, 2024, 11:23 |
Societies
Learn more about what was discussed during this major international conference - European School of Oncology
European School of Oncology shared on their LinkedIn page: "Learn more about what was discussed…
Jan 30, 2024, 11:13 |
Positive
Yüksel Ürün: Being together with Emre Yekedüz on the 20th anniversary of ASCO GU is a source of happiness and pride
Yüksel Ürün, Professor of Medical Oncology at Ankara University, shared on X/Twitter: "Being together with…
Jan 30, 2024, 10:56 |
Blog
Stephen V Liu: Congratulations to Drs. Glenn J. Hanna, Annie Silk and team - huge achievement!
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Jan 30, 2024, 07:44 |
Blog
An empowering day at the State House with the Rhode Island Medical Society and Students for a National Health Program - The Warren Alpert Medical School of Brown University
Jan 29, 2024, 19:29 |
Blog
Let's reflect on the insights that help create more inclusive and equitable cancer care - European Cancer Organisation
European Cancer Organisation made the following post on LinkedIn: "Ahead of World Cancer Day, let's…
Jan 29, 2024, 19:22 |
Blog
Toni Choueiri: This is humility at best
Toni Choueiri shared on LinkedIn: "The most iconic living oncologist (Larry Einhorn) who cured Testis Cancer,…
Jan 29, 2024, 19:04 |
Blog
Luis E. Raez: Our new Memorial Cancer Insititute West in Pembroke Pines in South Florida
Luis E. Raez, Medical Director of Memorial Cancer Institute, shared a post on LinkedIn: "Opening tomorrow…
Jan 29, 2024, 18:51 |
Blog
Jemma Arakelyan: An incredible ESMO Advanced Course on EGFR in Lung Cancer
Jemma Arakelyan, CEO of the Institute of Cancer and Crisis, shared on LinkedIn: “Thank you, European…
Jan 29, 2024, 18:44 |
Blog
Share the Call to Action demanding equity in cancer care! - Union for International Cancer Control
Union for International Cancer Control posted the following on LinkedIn: "World Cancer Day is a…
Jan 29, 2024, 17:46 |
Insight
Roberto Iacovelli: Different results from 2 phase 3 studies on adjuvant IO for mRCC... what's the reason?
Roberto Iacovelli, Associate Professor of Medical Oncology at Catholic University, Comprehensive Cancer Center of Rome…
Jan 29, 2024, 17:43 |
Insight
Minas Economides: First positive OS trial in adjuvant RCC
Minas Economides, GU Medical Oncologist and Assistant Professor of Medicine at NYU Langone Health, shared…
Jan 29, 2024, 17:38 |
Insight
Roberto Iacovelli: The results of CABATEN study presented at GU24
Roberto Iacovelli, Associate Professor of Medical Oncology at Catholic University, Comprehensive Cancer Center of Rome,…
Jan 29, 2024, 17:32 |
Insight
David Braun: Could really change how nivo is delivered in the future
David Braun, Oncologist, physician-scientist at Yale Cancer Center, shared a post on X/Twitter: "Really nice…
Jan 29, 2024, 17:28 |
Blog
Your gift of blood is a gift of life
January is more than just the start of a new year; it's the National Blood…
Jan 29, 2024, 15:08 |
Blog
Alex Swarbrick: Check out our chapter on Breast Cancer heterogeneity
Alex Swarbrick, Chair of Cancer Research Committee of the Cancer Council NSW, shared on X/Twitter:…
Jan 29, 2024, 14:55 |
Blog
David Almaguer: Don't forget that HSCT cures patients
David Almaguer, Professor of Hematology at Autonomous University of Nuevo León (UANL), shared on X/Twitter:…
Jan 29, 2024, 14:47 |
Blog
Roberto Iacovelli: Andrea Apolo at GU24 presented results of AMBASSADOR trial
Roberto Iacovelli, Associate Professor of Medical Oncology at Catholic University, Comprehensive Cancer Center of Rome,…
Jan 29, 2024, 14:37 |
Career
Christopher Conway: I’m starting a new position as Chief Executive Officer and Member of the Board of Directors at Tower Cancer Research Foundation
Christopher Conway, Founder of Philanthropic Counsel made the following post on LinkedIn: “I’m happy to…
Jan 29, 2024, 14:31 |
Blog
Erika Hamilton: An update in high risk HR+ bcsm
Erika Hamilton shared a post on LinkedIn: “Need a little bit of CME or want…
Jan 29, 2024, 14:13 |
History
Fabrice Andre: Academic clinical trials should be evaluated mainly based on their IMPACT on patients, not only on innovation
Fabrice Andre, Head of Research Division of Gustave Roussy, President Elect of the European Society…
Jan 29, 2024, 14:00 |
Blog
Lisa Lacasse: How we must continue to partner together to reduce disparities
Lisa Lacasse, President of the American Cancer Society Cancer Action Network, shared on LinkedIn: “A…
Jan 29, 2024, 13:54 |
Blog
Yousef Zakharia: The Right Person in the Appropriate Position as Editor in Chief for ASCO DailyNews
Yousef Zakharia, Associate Professor of Medicine at The University of Iowa shared a post by…
Jan 29, 2024, 13:48 |
Blog
Martin Angel: Elegant presentation by Sumanta K. Pal
Martin Angel, Clinical Oncologist at the Institute of Alexander Fleming, shared a post on X/Twitter:…
Jan 29, 2024, 13:41 |
Blog
Nina Niu Sanford: Our editorial on radiation omission trials is out in JCO Oncology Practice
Nina Niu Sanford, Assistant Professor of Radiation Oncology at UT Southwestern Medical Center, shared a…
Jan 29, 2024, 13:37 |
Blog
Sarah Sammons: Learning about Leptomeningeal Disease in Breast Cancer
Sarah Sammons, Breast Medical Oncologist at Dana-Farber's Breast Oncology Center, shared a post on X/Twitter:…
Jan 29, 2024, 13:33 |
Blog
Richard Sullivan: Superb work by Jordanian colleagues to develop Jordan's National Palliative and Home Care Strategic Framework
Richard Sullivan, Professor of Cancer and Global Health at King’s College London, shared a post…
Jan 29, 2024, 11:02 |
Blog
Matthijs Van Meerveld: No test, no treatment
Matthijs Van Meerveld, Associate Vice President of Global Head of Access Policy & Patient Advocacy,…
Jan 29, 2024, 10:53 |
Insight
Paolo Tarantino: The highly debated results of PALOMA2 now published on JCO
Paolo Tarantino, Medical Oncologist, PhD Università degli Studi di Milano, Research Dana-Farber Cancer Institute, Harvard…
Jan 29, 2024, 10:40 |
Blog
Petros Grivas: Our phase 2 trial of SG+Pembro in platinum-resistant IO-naive 2L setting
Petros Grivas, Clinical Director of Genitourinary Cancers Program, UW Medicine, shared on X/Twitter: "Excited for…
Jan 29, 2024, 10:32 |
Blog
Mark Lewis: Prophylactic gastrectomy is BRUTAL
Mark Lewis shared on X/Twitter: "Prophylactic gastrectomy is BRUTAL. We have to be so careful recommending…
Jan 29, 2024, 04:18 |
Societies
Registration is currently OPEN for the 5th SIOPE Annual Meeting in Milan - SIOPE
SIOPE shared on X/Twitter: "Did you know that registration is currently OPEN for the 5th…
Jan 29, 2024, 04:10 |
Blog
President Kovind presents Padma Shri to Dr. Ravi Kannan R. for Medicine - Rashtrapati Bhavan
Rashtrapati Bhavan shared on X/Twitter: "President Kovind presents Padma Shri to Dr Ravi Kannan R.…
Jan 29, 2024, 04:02 |
Blog
Patela Care Foundation provided cancer control health education, psychosocial counseling, and relief materials to IDPs at a camp in North Central Nigeria - Patela Care Foundation
Jan 29, 2024, 03:56 |
Insight
Myriam Chalabi: The Phase 2 PANDA Trial is out in Nature Medicine
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Antoni van Leeuwenhoek, The Netherlands Cancer…
Jan 28, 2024, 19:07 |
Blog
Omar Alhalabi: Matt needs no intro
Omar Alhalabi, Genitourinary Medical Oncologist at MD Anderson Cancer Center, shared an X post by…
Jan 28, 2024, 18:54 |
Societies
10 posts from ASCO GU 2024 by Yüksel Ürün
Yüksel Ürün, Professor of Medical Oncology at Ankara University, has recapped ASCO GU highlights on…
Jan 28, 2024, 18:47 |
Opinion
Daniel Stover: Excited to see early output from our Breast Cancer CNS Metastasis Group
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
Jan 28, 2024, 18:44 |
Blog
Interim phase 1 results show HPN328 is well tolerated and clinically active for neuroendocrine carcinomas - Dana-Farber News
Dana-Farber News recently shared a post on their X/Twitter page: "ASCO GU24: Interim phase 1…
Jan 28, 2024, 18:40 |
Blog
The International Association for the Study of Lung Cancer logo for the first World Conference on Lung Cancer
The International Association for the Study of Lung Cancer (IASLC) shared a post on X/Twitter:…
Jan 28, 2024, 18:36 |
Blog
Mark Lewis: Last Supper
Mark Lewis shared a post on his X/Twitter page: "I don’t know how much you’ve…
Jan 28, 2024, 18:29 |
Blog
Elisa Agostinetto: Estradiol levels remain the biomarker of choice
Elisa Agostinetto, Clinical Research Fellow at the Institute Jules Bordet, recently shared on X/Twitter: "Out…
Jan 28, 2024, 18:25 |
Blog
Time to start a new and exciting project - giving a voice to childhood cancer survivors - POINTE
Quoting POINTE on X/Twitter: "Time to start a new and exciting project - giving a…
Jan 28, 2024, 18:20 |
Blog
Michael Dickinson: So pleased to work with a great team of authors from around the world on these recommendations for bispecifics
Michael Dickinson, Haematologist at Peter MacCallum Cancer Centre, shared a post on X/Twitter: "So pleased to work…
Jan 28, 2024, 18:17 |
Blog
Luis E. Raez: There is no really benefit adding anti-VEGF to TKIs for EGFR tumors
Luis E. Raez, Medical Director of Memorial Cancer Institute, shared a post on X/Twitter: "Our metanalysis…
Jan 28, 2024, 16:31 |
Blog
Maite Bourlon: Happy to present the CheckMate9ER study at ASCO GU 2024
Maite Bourlon, the Head of the Urologic Oncology Clinic at Instituto Nacional de Ciencias Médicas…
Jan 28, 2024, 16:11 |
Drugs
Michael Serzan: About the hottest new ICI BOTENSILIMAB in Kidney Cancer?
Michael Serzan, Genitourinary Medical Oncologist from Dana-Farber Cancer Institute, shared on X: " Interested in…
Jan 28, 2024, 15:04 |
Blog
Drew Moghanaki: RECIST over-classified 'progression' in 81% of cases without progression.
Drew Moghanaki, Chief of Thoracic Oncology in the UCLA Department of Radiation Oncology, shared a post…
Jan 28, 2024, 15:00 |
Blog
Ted Yanagihara: Extremity sarcoma can throw unexpected challenges our way
Ted Yanagihara, Assistant Professor of Radiation Oncology at UNC School of Medicine, shared a post on…
Jan 28, 2024, 14:51 |
Blog
Metastatic prostate cancer – site of metastasis matters
By Marcos Franca During the rapid oral abstract session A: prostate cancer in ASCO –…
Jan 28, 2024, 14:49 |
Blog
Richard Dunne: Us oncologists continue to think about you and your family too
Mark Lewis shared a post by Richard Dunne, Associate Professor of Medicine in the Department of…
Jan 28, 2024, 13:56 |
Opinion
The 2 candidates for ESTRO President: Barbara Jereczek-Fossa and Dirk Verellen
ESTRO shared a post on X/Twitter: "Election time coming up! We’re delighted to unveil the…
Jan 28, 2024, 13:41 |
Blog
Denis Jardim: Hispanics are highly underrepresented in oncology clinical trials by Dr. Cheryl Lee
Denis Jardim, Chief of GU Cancer at Grupo Oncoclínicas, made the following post on X:…
Jan 28, 2024, 13:38 |
Blog
Zainab Shinkafi-Bagudu: We are embarking on an artistic journey to mark World Cancer Day and close the care gap, on Feb 9th.
Zainab Shinkafi-Bagudu shared a post on X/Twitter: "Along with our friends Johnson and Johnson Global Health,…
Jan 28, 2024, 13:27 |
Blog
MaryLisabeth Rich: Thank you to CEO Roundtable on Cancer Members and Partners who made yesterday's Moonshot Cancer Care Equity Summit possible
MaryLisabeth Rich, President at CEO Roundtable on Cancer, posted the following on LinkedIn: "Thank you…
Jan 28, 2024, 13:16 |
Blog
Robin Zon: An opportunity for State Legislators to share and listen
Robin Zon, the Director of Breast Oncology at Cincinnati Cancer Advisors, recently shared on LinkedIn:…
Jan 28, 2024, 13:07 |
Opinion
Olalekan Ajayi: Exciting Insights from Hospital Oncologico, San Juan, Puerto Rico
Olalekan Ajayi, Chief Operating Officer of Highlands Oncology Group and President of Association of Community Cancer…
Jan 28, 2024, 13:03 |
Blog
Let's talk about a powerful shield against cervical cancer - HPV VACCINES! - Medicaid Cancer Foundation
Medicaid Cancer Foundation shared a post on LinkedIn: "Let's talk about a powerful shield against cervical…
Jan 28, 2024, 12:59 |
Blog
Michelle Kirschner: I was able to join in NCI Office of Cancer Survivorship program
Michelle Kirschner, Medical Advisory Board Chairman at OneVillage, recently shared a post on LinkedIn: "I…
Jan 28, 2024, 12:55 |
Blog
Hil Moss: Three high-level takeaways from Cancer Facts and Figures report
Hil Moss, the Co-Founder/CEO of VivorCare, recently shared on LinkedIn: "This week, the American Cancer…
Jan 28, 2024, 12:51 |
Blog
Gemma Peters: Some thoughts and learnings from these past 12 months and how we’re looking to Macmillan’s future
Gemma Peters, Chief Executive Officer of Macmillan Cancer Support, recently shared on LinkedIn: "It’s been…
Jan 28, 2024, 12:51 |
Blog
Sean Lybrand: Discussing the progress of the Readiness for Access to Cancer Medicines program in Paraguay
Sean Lybrand, Executive Director at Amgen, shared on LinkedIn: “In Geneva this week, focusing on…
Jan 28, 2024, 12:42 |
Blog
Mike Hoerger: In a "bleak milestone," new cancer diagnoses exceed 2 million/year for the 1st time in U.S. history
Mike Hoerger, Director of the top public U.S. COVID forecasting dashboard (PMC), made the following…
Jan 28, 2024, 11:45 |
Blog
Rebecca Shatsky: Why on earth would insurance get to decide how I practice medicine!
Rebecca Shatsky shared on X/Twitter: "Just found out an insurance company is trying to deny my…
Jan 28, 2024, 10:45 |
Blog
Peter Pisters: Superb efforts toward fostering a personalised and compassionate environment for our patients
Peter Pisters, President of The University of Texas MD Anderson Cancer Center, shared a post…
Jan 28, 2024, 09:08 |
Blog
Terry Williams: No doubt she will be a great partner to drive transformative change in our radonc and oncology programs
Terry Williams, Professor and Chair of the Department of Radiation Oncology at the City of…
Jan 28, 2024, 09:01 |
Stories
David Fajgenbaum: Even in our darkest hours, there's potential for incredible triumph
David Fajgenbaum, Physician-scientist at the University of Pennsylvania, shared a post on X/Twitter: “When I…
Jan 28, 2024, 08:46 |
Blog
Dong-Woo Kang: Honoured to receive the National Cancer Institute K99/R00 pathway to independence grant
Dong-Woo Kang, Instructor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute, recently shared…
Jan 28, 2024, 05:57 |
Blog
Giacomo Gorini: Phase II results of an anti-melanoma mRNA vaccine by Moderna and Merck
Giacomo Gorini, antibody immunologist from the Ragon Institute of Mass General, MIT, and Harvard, shared…
Jan 28, 2024, 05:50 |
Blog
Adam Selipsky: Hurone AI is incorporating Amazon Bedrock in its cancer care platform, making care more accessible for patients in Rwanda, Kenya, and Nigeria
Adam Selipsky, CEO at Amazon Web Services (AWS), shared on LinkedIn: "More than 700 million…
Jan 28, 2024, 04:00 |
Blog
Vincent Rajkumar: These are two incredible leaders and thinkers and they helped make my career
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, shared a post…
Jan 27, 2024, 22:56 |
Blog
Antonio Passaro: This scientific journey has not only been immensely interesting but exceptionally fruitful
Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared on LinkedIn: "Delighted to…
Jan 27, 2024, 22:42 |
Blog
John Houston: Thanks for the great write up on the exciting events happening at Arvinas!
John Houston, Chairperson, CEO and President at Arvinas (NASDAQ ARVN), shared the following post by…
Jan 27, 2024, 22:35 |
Blog
Six fantastic articles to get you up to speed on all things screening, HPV, and cervical cancer - Cancer Research UK (CRUK)
Cancer Research UK (CRUK) made the following post on LinkedIn: "Cervical cancer is the fourth…
Jan 27, 2024, 22:27 |
Blog
Christos Hatzis: The impact of early detection and improved therapeutic options on reducing cancer-related mortality
Christos Hatzis, VP, Global Head of Translational Medicine at HiFiBio Therapeutics, made the following post…
Jan 27, 2024, 22:20 |
Blog
Our Lianna dreams of becoming a model - City of Smile Charitable Foundation
City of Smile Charitable Foundation made the following post on LinkedIn: "Introducing Lianna, our delightful…
Jan 27, 2024, 22:12 |
Career
Selwyn Vickers: It's an honor to join the 18 distinguished MSK faculty who are fellows of the AACR Academy class of 2024
Selwyn Vickers, President and CEO of Memorial Sloan Kettering Cancer Center, recently shared a post…
Jan 27, 2024, 22:07 |
Blog
Ani Haykuni: I was so pleased to speak at TEDxOxford last Saturday
Ani Haykuni, Founder and CEO of Vann, shared on LinkedIn: “I was so pleased to speak…
Jan 27, 2024, 20:44 |
Blog
Tanya Zlatanova: It was my honor to be among the distinguished faculty of the 4th Thoracic Cancer Academy
Tanya Zlatanova, Medical Oncologist at Acibadem City Clinic Tokuda Hospital, Sofia, recently posted on LinkedIn:…
Jan 27, 2024, 20:41 |
Blog
Prof. Lillian Sung's input has been instrumental to increase the scientific quality of our research and build the program - CANCaRe Africa
CANCaRe Africa shared on their LinkedIn: "The CANCaRe Africa team would like to thank Prof…
Jan 27, 2024, 20:33 |
Blog
Aruni Ghose: Our amazing Prostate Cancer poster at ASCO GU24
Aruni Ghose, Focused Topic Network Member at European Cancer Organisation, shared a LinkedIn post by Mona…
Jan 27, 2024, 20:28 |
Career
Brian Mulherin has been appointed to serve as AON’s new Medical Director - American Oncology Network
American Oncology Network recently announced on their LinkedIn page: "We're pleased to announce that Dr.…
Jan 27, 2024, 17:17 |
Societies
ASCO GU 2024 – New insights in clear cell renal cancer (RCC) – Adjuvant perspectives
By Marcos Franca During the morning in ASCO GU 2024 meeting, in San Francisco –…
115
116
117
118
119
All:
16105
Posts:
11601 - 11700
Why does Lionel Messi donate so much to charity?
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Facebook
RSS Feed
Twitter
Linkedin
Youtube